EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02016378|
Recruitment Status : Active, not recruiting
First Posted : December 20, 2013
Last Update Posted : January 14, 2020
|Condition or disease||Intervention/treatment||Phase|
|Alcohol Use Disorder||Behavioral: Bias retraining Behavioral: Sham retraining||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||25 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2020|
Sham Comparator: sham retraining
Participants in this condition will participate in a computerized task wherein the size of pictures of drug and non-drug related stimuli are increased or decreased based on the tilt (left or right) of the pictures, but without regard to the content (i.e., drug or non-drug).
Behavioral: Sham retraining
Participants will view pictures of drug and non-drug related stimuli on a computer. Participants will then use the computer to make the pictures larger or smaller based on the tilt of the picture (slightly to the left or right), but without regard to the content of the picture.
Active Comparator: Bias retraining
Participants in this condition will participate in 6 sessions of a computerized bias retraining.
Behavioral: Bias retraining
Participants will view pictures of drug (e.g., alcohol) and non-drug stimuli (e.g., soft drinks) on a computer. Participants will then use the computer to make the drug pictures smaller and the non-drug pictures larger.
- Change in Youth Outcome Questionnaire-Self-report scores [ Time Frame: baseline, 6 weeks and 6 months after the start of treatment ]This instrument is used to track symptoms throughout treatment. It will be used at baseline, 2x week for 2 weeks, 6 weeks from baseline (end of treatment), and at a 6 month follow-up assessment. The primary outcome is the growth curve of the scores over time.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02016378
|United States, Michigan|
|University of Michigan Addiction Research Center|
|Ann Arbor, Michigan, United States, 48109|
|Principal Investigator:||Brian Hicks, PhD||University of Michigan|